instruction:
Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.
question:
Paragraph: A panel of Food and Drug Administration advisers voted unanimously in favor of Amgen’s version of AbbVie’s Humira, a biotech drug that raked in nearly $15 billion last year, according to IMS Health. While not binding, the recommendation likely paves the way for FDA approval of the knockoff drug. For years, biotech drugs faced no competition because there was no regulatory way to approve copycat versions, even after patents had expired. If approved, Amgen’s drug would join a new wave of so-called biosimilars, which have the potential to generate billions in savings for U.S. insurers, doctors and patients. But it could take years for those savings to arrive. Evercore ISI analyst Mark Schoenebaum says the earliest Amgen could launch its product would be March 2017, though that would risk infringing patents which Abbvie says protect its drug until at least 2022. Wall Street analysts expect the patent issue to be fought in court, and then for Amgen’s drug to launch sometime between 2018 and 2022. First approved in 2002, Humira has long been among the most profitable drugs in the world. It accounted for 60 percent of Abbvie’s total revenue last year. The injectable drug, which blocks chemicals linked to inflammation, is approved for multiple uses, including rheumatoid arthritis, Crohn’s disease and psoriasis. Thousand Oaks, Calif-based Amgen is seeking FDA approval to market its version, known only as ABP 501, for seven diseases. Amgen is itself a biotech powerhouse, and it too has medications facing competition from cheaper versions. The company is working to hedge those loses by developing lower-cost versions of competitors’ drugs. Biotech drugs are powerful, injected medicines produced in living cells that are typically much more expensive than traditional, chemical-based drugs. In 2015, six of the 10 top-selling medicines globally were biotech drugs, with more than $56 billion in combined sales. The FDA only approved the first lower-cost biotech drug last March, a Novartis version of the Amgen drug Neupogen. Pfizer won approval to market a second biosimilar in April, a version of Johnson & Johnson’s Remicade, but it is not yet for sale. Questions remain about just how much savings U.S. biosimilars will deliver. Novartis’ Zarxio sells for 15 percent less than the original Neupogen. Experts predict biosimilar discounts of 15 percent to 30 percent in the U.S. In Europe, where governments regulate prices, discounts are higher. Development of lower-cost anti-inflammatory drugs like Humira is considered pivotal in reducing U.S. spending on specialty drugs, which has doubled to $150 billion since 2010, according to IMS Health. On Wednesday, the same panel of FDA advisers will review a Novartis version of Enbrel, which is marketed by Amgen. Claim: Lower-cost biotech drug gets thumbs up from FDA panel.
answer:
The second-biggest selling drug in the world could get some cheaper competition in the U.S., after a federal panel endorsed an alternative version of the pricey medication used to treat rheumatoid arthritis and other inflammatory diseases.


question:
Paragraph: "Pitching for a bump in the minimum wage, a labor leader suggested a hike could save all Texans money by elevating low-income workers who’d no longer need government help. We don’t know about that. But we flipped on the Texas Truth-O-Meter after John Patrick, president of the Texas AFL-CIO, said at a January 2017 Capitol press conference: ""If you have a family, the current minimum wage easily qualifies you for food stamps."" Really? ""Food stamps"" is an outdated term referring to food benefits available to income-eligible residents through the federal Supplemental Nutrition Assistance Program. Beneficiaries purchase food and groceries using electronic benefit transfer cards. Nationally on average in 2015, about 45.8 million people in 22.5 million households monthly participated in SNAP, according to the federal government, and because benefits are available to most low-income households, participants represent a broad cross-section of the nation's poor. A November 2016 U.S. Department of Agriculture report states that in the year, 55 percent of SNAP households with children included people with jobs. Still, the average gross income of participating households was $786 a month, the report says, which breaks out to $9,432 a year. We asked the Texas AFL-CIO for the basis of Patrick’s claim. By email, spokesman Ed Sills said a full-time minimum-wage Texas worker earns $7.25 an hour (identical to the federal minimum). Multiplied over 2,000 work hours in a year, that’s an annual income of approximately $14,500. The labor group’s use of 2,000 hours in a work year contrasts with the 2,087-hour work year used by the federal government in its data assumptions. Using that figure, a single full-time worker would earn $15,130 in a year. Sills otherwise said that according to maximum monthly income limits posted by the state, a family could easily qualify for SNAP with a single worker earning the minimum wage. He pointed out the relevant chart, posted on a Texas Health and Human Services Commission web page titled  ""SNAP Food Benefits."" We proceeded to crunch the figures, which mostly supported Patrick’s claim, though we also noticed Patrick hadn’t said if he was thinking solely of families with one full-time minimum-wage worker; Sills told us by phone that he believed so. A twist Then came a twist causing us to realize the commission-posted figures were out of date. We recognized as much when Christine Mann, a commission press officer, responded to our inquiry about Patrick’s claim by providing SNAP-eligibility household income thresholds lower than the thresholds on the agency’s SNAP food benefits web page--which Mann told us would be updated. Mann later provided a commission web link to the up-to-date income eligibility figures. For our part, we spotted the same income-eligibility numbers on a USDA web page that describes the figures as in effect for the fiscal year running through September 2017. Mann’s response also indicated that qualifying for SNAP is more complicated than simply grossing less than a particular threshold. ""Eligibility for SNAP is based on household size, the countable amount of gross and net income for all mandatory household members, and allowed deductions"" for items including shelter, utilities, child care and medical expenses, Mann wrote. Agency confirmation Mann otherwise told us that a single minimum-wage full-time worker in a household of two to three people would draw monthly gross income of $1,255.70. In support of Patrick’s claim, that amount runs short of the up-to-date income thresholds to qualify for SNAP of $1,736 a month for a two-person household or $2,184 a month for a three-person household. Bigger households with a single full-time minimum-wage worker would qualify too, we calculated, as would households of four or more with two full-time minimum-wage workers. We identified one exception: A household of three with two full-time minimum-wage workers, which would have a combined gross monthly income of $2,511.40, would earn too much to qualify for SNAP at the qualifying gross-income threshold of $2,184 a month for a household of three. We separately asked the Austin-based Center for Public Policy Priorities, which says it advocates for conditions enabling every Texan to be healthy, well-educated and financially secure, to assess Patrick’s statement. By email, Oliver Bernstein described calculations like our own; he said the claim holds up. Our ruling Patrick said that in Texas, ""if you have a family, the current minimum wage easily qualifies you for food stamps."" Our finding is that a household of two or more residents including a single full-time minimum-wage worker would clearly qualify for SNAP as would a household of four or more with two full-time minimum-wage workers. A three-person household with two such workers would gross too much to qualify. – The statement is accurate but needs clarification or additional information. Claim: If you have a family, the current minimum wage easily qualifies you for food stamps.
answer:
"Patrick said that in Texas, ""if you have a family, the current minimum wage easily qualifies you for food stamps."" Our finding is that a household of two or more residents including a single full-time minimum-wage worker would clearly qualify for SNAP as would a household of four or more with two full-time minimum-wage workers. A three-person household with two such workers would gross too much to qualify."


question:
Paragraph: The Georgia Department of Public Health said Monday the family’s cases appear to have originated during travel out of the state. Two other families in Cobb County have been affected, and all 11 people were either not vaccinated or did not have a clear vaccination status. Health officials say they are continuing to notify people who may have been exposed and could face an increased risk of contracting the virus. Measles is highly contagious. The U.S. has experienced a resurgence of the illness that’s fueled by outbreaks in unvaccinated communities. Claim: Georgia officials identify likely source of measles outbreak.
answer:

Georgia health officials say a family of five is the likely source of a measles outbreak in a metro Atlanta county that has sickened 11 people.